The Bisoprolol Fumarate and Hydrochl, cataloged under National Stock Number 6505-01-384-5864, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sandoz Consumer Health Care Group. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 8 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-384-5864 |
| Primary Part Number | NDC00781-1824-01 |
| Item Name | Bisoprolol Fumarate and Hydrochl |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sandoz Consumer Health Care Group |
| Status | ACTIVE |
| General Characteristics Item Description | 5 MG BISOPROLOL FUMARATE AND 6.25 MG HYDROCHLOROTHIAZIDE; 100 TABLETS PER BOTTLE; THERAPEVTIALLY EQUIVALENT TO ZIAC BY LEDERLE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00781-1824-01 PRIMARY | Sandoz Consumer Health Care Group (USA) |
| NDC51285-0050-02 PRIMARY | Duramed Pharmaceuticals, Inc (USA) |
| ZIAC | Duramed Pharmaceuticals, Inc (USA) |
| NDC00378-0503-01 PRIMARY | Mylan Pharmaceuticals Inc (USA) |
| ZIAC | Mylan Pharmaceuticals Inc (USA) |
| NDC51079-0955-20 | Mylan Institutional Inc Dba Mylan Institutional (USA) |
| NDC00591-0842-01 | Danbury Pharmacal Inc (USA) |
| NDC00185-0704-01 | Sandoz Inc. (USA) |
| Reference | Meaning |
|---|---|
| NDC00185-0704-01 | 5/9 Secondary reference Eon Labs, Inc. |
NSN 6505-01-384-5864 is a Bisoprolol Fumarate and Hydrochl, manufactured by Sandoz Consumer Health Care Group, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-384-5864 has 8 manufacturer part numbers on file: NDC00781-1824-01 (Sandoz Consumer Health Care Group), NDC51285-0050-02 (Duramed Pharmaceuticals, Inc), ZIAC (Duramed Pharmaceuticals, Inc), NDC00378-0503-01 (Mylan Pharmaceuticals Inc), ZIAC (Mylan Pharmaceuticals Inc) and 3 more.
Key specifications for NDC00781-1824-01: General Characteristics Item Description: 5 MG BISOPROLOL FUMARATE AND 6.25 MG HYDROCHLOROTHIAZIDE; 100 TABLETS PER BOTTLE; THERAPEVTIALLY EQUIVALENT TO ZIAC BY LEDERLE; Part Name Assigned by Controlling Agency: BISOPROLOL FUMATATE AND HYDROCHLOROTHIAZIDE TABLETS 100S BT. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.